These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 3908169)
41. Partial restoration of hair growth in the DEBR model for Alopecia areata after in vivo depletion of CD4+ T cells. McElwee KJ; Spiers EM; Oliver RF Br J Dermatol; 1999 Mar; 140(3):432-7. PubMed ID: 10233262 [TBL] [Abstract][Full Text] [Related]
42. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata. Tobin DJ; Gardner SH; Lindsey NJ; Hoffmann R; Happle R; Freyschmidt-Paul P Eur J Dermatol; 2002; 12(4):327-34. PubMed ID: 12095876 [TBL] [Abstract][Full Text] [Related]
43. The correlation between inducer/suppressor ratios, generation of concanavalin A-activated suppressor cells, and mitogen-stimulated proliferation of peripheral blood lymphocytes in patients with alopecia areata and normal controls. Filipovich AH; Hordinsky-Kramarczuk M; Nelson D; Hallgren H Clin Immunol Immunopathol; 1982 Oct; 25(1):21-31. PubMed ID: 6217938 [No Abstract] [Full Text] [Related]
44. Cytotoxic T-lymphocyte antigen 4 (CTLA4) +49AG and CT60 gene polymorphisms in Alopecia Areata: a case-control association study in the Italian population. Megiorni F; Mora B; Maxia C; Gerardi M; Pizzuti A; Rossi A Arch Dermatol Res; 2013 Sep; 305(7):665-70. PubMed ID: 23567921 [TBL] [Abstract][Full Text] [Related]
45. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. Gupta AK; Ellis CN; Cooper KD; Nickoloff BJ; Ho VC; Chan LS; Hamilton TA; Tellner DC; Griffiths CE; Voorhees JJ J Am Acad Dermatol; 1990 Feb; 22(2 Pt 1):242-50. PubMed ID: 2138175 [TBL] [Abstract][Full Text] [Related]
46. Subsets of lymphoid cells in blood and thymus in myasthenia gravis. Monoclonal antibody analysis. Fujii N; Itoyama Y; Tabira T; Kuroiwa Y J Neuroimmunol; 1983 Jun; 4(3):151-9. PubMed ID: 6343429 [TBL] [Abstract][Full Text] [Related]
47. Lesional infiltration of mast cells, Langerhans cells, T cells and local cytokine profiles in alopecia areata. Zhang X; Zhao Y; Ye Y; Li S; Qi S; Yang Y; Cao H; Yang J; Zhang X Arch Dermatol Res; 2015 May; 307(4):319-31. PubMed ID: 25638328 [TBL] [Abstract][Full Text] [Related]
48. Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes. Herbst V; Zöller M; Kissling S; Wenzel E; Stutz N; Freyschmidt-Paul P Eur J Dermatol; 2006; 16(5):537-42. PubMed ID: 17101475 [TBL] [Abstract][Full Text] [Related]
49. [Peripheral T-lymphocyte subsets changes in patients with endocrine and metabolic diseases]. Li QF; Li YP; Cheng PS Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):410-2, 444. PubMed ID: 2591260 [TBL] [Abstract][Full Text] [Related]
50. Early stage alopecia areata is associated with inflammation in the upper dermis and damage to the hair follicle infundibulum. Zhang B; Zhao Y; Cai Z; Caulloo S; McElwee KJ; Li Y; Chen X; Yu M; Yang J; Chen W; Tang X; Zhang X Australas J Dermatol; 2013 Aug; 54(3):184-91. PubMed ID: 23808570 [TBL] [Abstract][Full Text] [Related]
51. Intrabulbar and peribulbar accumulation of dendritic OKT 6-positive cells in alopecia areata. Wiesner-Menzel L; Happle R Arch Dermatol Res; 1984; 276(5):333-4. PubMed ID: 6548356 [No Abstract] [Full Text] [Related]
52. Alopecia areata treated with efalizumab: a case with significant hair re-growth after long-term therapy. Smith JR; Akin RS; Wells MJ J Drugs Dermatol; 2009 Aug; 8(8):758-60. PubMed ID: 19663114 [TBL] [Abstract][Full Text] [Related]
53. Alopecia areata, autoimmunity, and Down's syndrome. Du Vivier A; Munro DD Br Med J; 1975 Jan; 1(5951):191-2. PubMed ID: 122906 [TBL] [Abstract][Full Text] [Related]
55. [Increase in Leu7- Leu11+ cells in the peripheral blood lymphocytes of patients with alopecia areata]. Imai R; Miura J; Takamori K Nihon Hifuka Gakkai Zasshi; 1989 Apr; 99(4):503-5. PubMed ID: 2482377 [TBL] [Abstract][Full Text] [Related]
56. Differential expression of CXCL1, CXCL9, CXCL10 and CXCL12 chemokines in alopecia areata. Zainodini N; Hassanshahi G; Arababadi MK; Khorramdelazad H; Mirzaei A Iran J Immunol; 2013 Mar; 10(1):40-6. PubMed ID: 23502337 [TBL] [Abstract][Full Text] [Related]
57. Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata. Guttman-Yassky E; Nia JK; Hashim PW; Mansouri Y; Alia E; Taliercio M; Desai PN; Lebwohl MG Arch Dermatol Res; 2018 Oct; 310(8):607-614. PubMed ID: 30121698 [TBL] [Abstract][Full Text] [Related]
58. Immunofluorescent studies of complement C3 in the hair follicles of normal scalp and of scalp affected by alopecia areata. Igarashi R; Takeuchi S; Sato Y Acta Derm Venereol; 1980; 60(1):33-7. PubMed ID: 6153831 [TBL] [Abstract][Full Text] [Related]